Resource Center
Explore Resource Types
We have housed the technical documents (SDS, COAs, Manuals and more) in a dedicated section.
Explore all All Resources
Filters
Select resource types
Select products & services
Select solutions (3)
Active Filters (3)
Clear All
1 - 12 of 56 Results
Sort by:
Best Match
Flyer
The T-SPOT.CMV test assesses a patient’s level of anti-CMV cell-mediated immunity
Explore how Cytomegalovirus (CMV) cell-mediated immunity and the T-SPOT.CMV test can enhance understanding of CMV immune status, crucial for managing patients at risk of disease after organ and stem cell transplants.
Other
Technical Note
Package insert for the T-SPOT.TB test
The T-SPOT.TB test is an in vitro diagnostic test for the detection of effector T cells that respond to stimulation by Mycobacterium tuberculosis antigens and is intended for use as an aid in the diagnosis of tuberculosis (TB) infection. The T-SPOT.TB test is a simplified enzyme-linked immunospot (ELISPOT) method which enumerates individual TB-specific activated effector T cells.
Specification Sheet
Flyer
"Understanding your vaccine and immunotherapy efficacy"
Certimmune from Revvity provides tailored immunology services for vaccine and immunotherapy clinical trials, leveraging 20 years of expertise and global lab networks.
Product Info
Oxford Diganostic Laboratories terms and conditions
The terms and conditions of service from Oxford Diagnostic Laboratories
Brochure
A trusted partner for adaptive immunity testing for clinical trials
Certimmune’s global immunology services are brought to you by Revvity. Certimmune is built on the foundations of Revvity nearly 20 years experience developing more reliable, high throughput, standardized tests for measuring the adaptive immune system.
Application Note
Effectiveness of CRISPR-Cas9 using pools of Dharmacon™ Edit-R™ synthetic crRNAs in high-content analysis screening experiments
Find out about the effectiveness of CRISPR-Cas9 using pools of Dharmacon™ Edit-R™ synthetic crRNAs in HCA screening experiments.
Application Note
Pooled phenotypic CRISPR screening enables the identification of synergistic drug combinations for cancer therapy
This application note demonstrates how a pooled phenotypic CRISPR screening can be used to identify synergistic drug combinations for cancer therapy
Literature - Publication Review
Linking genes to phenotypes with CRISPR screening
Literature review on the multiple CRIPSR screening techniques available for drug discovery and their benefits.
Whitepaper
Overcoming hurdles in high-throughput profiling of cancer cell responses
Presenting case studies on how functional genomic screening is used to find therapeutic targets, identify patient populations, uncover MoA, investigate drug combinations, and reveal drug resistance and sensitivity
Whitepaper
CRISPR-Cas9 screening: a powerful approach to advance drug discovery
Find out about the potential of CRISPR-Cas9 screening for drug discovery in this white paper.
Looking for technical documents?
Find the technical documents you need, ASAP, in our easy-to-search library.